Official matched intervention · Drug

thymosin alpha 1 clinical trials

3 selected ClinicalTrials.gov records carrying the official matched intervention thymosin alpha 1 (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.

Registry records

3 selected records.

Connected peptides

1 profiles.

Source boundary

ClinicalTrials.gov intervention field.

Cross-source journeys

Explore connected peptide records

Across these connected profiles, PeptideScanner carries 30 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.

Collection change ledger

Recently changed records on this intervention hub

All recent changes →

These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.

Record added

ClinicalTrials.gov record NCT02646189

PeptideScanner retained ClinicalTrials.gov record NCT02646189 at 2026-11-15T22:10:40.222Z. Its registry update date was 2016-01-05, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
January 5, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02883595

PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
April 4, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03659578

PeptideScanner retained ClinicalTrials.gov record NCT03659578 at 2026-11-15T22:10:40.222Z. Its registry update date was 2022-01-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
January 3, 2022
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →